Improve correctional TB testing with QuantiFERON-TB Gold Plus
Correctional facilities play a critical role in controlling TB. Join Dr. Masae Kawamura as she discusses recent policy advancements that are helping prevent tuberculosis in jails and prisons. You'll learn about the latest diagnostic tools for TB infection as well as new preventative treatment regimens that are increasing compliance and decreasing cost.
In this recorded webinar, Dr. Kawamura answers top questions from your colleagues, such as how IGRA testing can help mitigate the current skin test (TST/PPD) shortage. Through case studies and publications, you'll learn why the CDC recommends modern TB blood tests and how they can streamline testing at your facility.
Dr. Masae Kawamura is a former TB Controller and current Senior Director of Scientific and Medical Affairs for TB diagnostics at QIAGEN.
REGISTER BELOW to view the on-demand webinar
QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to-date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.